glp 1 vs sglt2 Diabetic Agents, From Metformin to Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar SGLT2 inhibitors or GLP-1 receptor
Description
The results showed that liraglutide increased the expression of ALP, Col-1 and Runx2 mRNA, and decreased the expression of peroxisome proliferator-activated receptor (PPAR) (Lu et al., 2015)
Transitioning from basal-bolus or premix insulin therapy to a combination of basal insulin and glucagon-like peptide-1 receptor agonist in people with type 2 diabetes
Want to dig deeper
GLP-1 medications produce 15 to 20% body weight reduction in clinical trials through pharmacological hormone mimicry at concentrations far above natural production
No insurance is needed, we offer transparent out-of-pocket prices
Tirzepatide (Mounjaro, Zepbound) Mounjaro is approved for type 2 diabetes
